CD38 and cancer: Because human bodies are exposed to varieties of pathogens and aging patients often have comorbidity with various chronic inflammation (including atherosclerosis, cardiovascular events, cancer, autoimmune diseases), aging patients could have high levels of CD38+ and reduced levels of NAD+ compared with the young controls.